Know Cancer

or
forgot password

Epidemiology of Celiac Disease: A Prospective Study of Undiagnosed Celiac Disease in the Community


N/A
60 Years
N/A
Not Enrolling
Both
Celiac Disease

Thank you

Trial Information

Epidemiology of Celiac Disease: A Prospective Study of Undiagnosed Celiac Disease in the Community


Inclusion Criteria:



- At least 60 years old

- Male and female

Retrospective testing for celiac disease was done on previously stored serum. Contacting
specific individuals for inclusion into study

Type of Study:

Interventional

Study Design:

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Understanding the impact of undiagnosed celiac disease and the potential benefits of diagnosis

Outcome Description:

To understanding the impact of undiagnosed celiac disease and the potential benefits, detection and treatment may have a substantial impact on the health of these subjects and the large numbers of Americans with undiagnosed celiac disease. The outcome measures we will be looking at are Quality of Life, GI Symptoms including diarrhea, constipation, abdominal pain, Tissue Transglutaminase level improvement after 12 weeks on a gluten free diet, bone density, understanding of a gluten free diet.

Outcome Time Frame:

one year

Safety Issue:

No

Principal Investigator

Joseph Murray, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Mayo Clinic

Authority:

United States: Institutional Review Board

Study ID:

10-000178

NCT ID:

NCT01317914

Start Date:

July 2010

Completion Date:

April 2012

Related Keywords:

  • Celiac Disease
  • Celiac Disease

Name

Location

Mayo Clinic in RochesterRochester, Minnesota  55905